INTRAVASCULAR PAPILLARY ENDOTHELIAL HYPERPLASIA

This adverse event was reported 29 times

These drugs are most commonly taken by patients reporting INTRAVASCULAR PAPILLARY ENDOTHELIAL HYPERPLASIA:

# Drug Count
0 OLANZAPINE 9
1 SOMATROPIN 3
2 ETANERCEPT 2
3 METHYLPREDNISOLONE 2
4 MYCOPHENOLATE MOFETIL 2
5 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 2
6 PREDNISONE 2
7 SIROLIMUS 2
8 SODIUM BICARBONATE 2
9 SODIUM BICARBONATE INJECTION, 2
See all common drugs associated with INTRAVASCULAR PAPILLARY ENDOTHELIAL HYPERPLASIA

INTRAVASCULAR PAPILLARY ENDOTHELIAL HYPERPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 POTASSIUM BICARBONATE 1 0.0014
1 TRABECTEDIN 1 0.0004
2 PYRIDOXINE HYDROCHLORIDE 1 0.0004
3 POTASSIUM CITRATE 1 0.0002
4 SIROLIMUS 2 0.0001
5 OLANZAPINE 9 0.0001
6 SODIUM BICARBONATE INJECTION, 2 0.0001
7 BASILIXIMAB 1 0.0001
8 PEGFILGRASTIM 1 0.0001
9 SOMATROPIN 3 0.0000
See all drugs enriched for association with INTRAVASCULAR PAPILLARY ENDOTHELIAL HYPERPLASIA